These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23256811)
1. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors. Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811 [TBL] [Abstract][Full Text] [Related]
2. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors. Thangapandian S; John S; Sakkiah S; Lee KW Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770 [TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design. Thangapandian S; John S; Arooj M; Lee KW PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831 [TBL] [Abstract][Full Text] [Related]
4. Classification and QSAR models of leukotriene A4 hydrolase (LTA4H) inhibitors by machine learning methods. Qin R; Wang H; Yan A SAR QSAR Environ Res; 2021 May; 32(5):411-431. PubMed ID: 33896285 [TBL] [Abstract][Full Text] [Related]
5. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase. Thangapandian S; John S; Sakkiah S; Lee KW J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343 [TBL] [Abstract][Full Text] [Related]
6. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking. Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506 [TBL] [Abstract][Full Text] [Related]
7. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses. Appiah-Kubi P; Soliman ME J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301 [TBL] [Abstract][Full Text] [Related]
8. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors. Sonawane LV; Bari SB Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764 [TBL] [Abstract][Full Text] [Related]
9. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs. Appiah-Kubi P; Soliman M Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004 [TBL] [Abstract][Full Text] [Related]
10. A Structure Guided QSAR: A Rapid and Accurate technique to predict IC50: A Case Study. Mishra RK; Singh J Curr Comput Aided Drug Des; 2015; 11(2):152-63. PubMed ID: 26135341 [TBL] [Abstract][Full Text] [Related]